packageIronOxideNanoparticles

iron oxide, nanoparticles

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Iron oxide nanoparticles are used as a superparamagnetic contrast agent for magnetic resonance imaging. They are approved and also under investigation for further uses.

Summary written by glm-5.3-flash from Wikidata Q419170 and the WHO ATC classification; not checked by a person.

name:iron oxide, nanoparticles
ATC codes:V08CB03
DrugBank:DB11576
ChEBI:50819
Wikidata:Q419170
formula:Fe2O3
molar mass:159.687 g/mol (knowledgebase (DrugBank calculated))
logP:0.37 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown